You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 5, May 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  KEMPE FESTSCHRIFT-CONTINUED
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Varicella Vaccine Trials in Healthy Children

A Summary of Comparative and Follow-up Studies

Allan M. Arbeter, MD; Stuart E. Starr, MD; Stephen R. Preblud, MD; Toshiaki Ihara, MD; Patricia M. Paciorek; Deborah S. Miller; Cindy M. Zelson; Elinor A. Proctor; Stanley A. Plotkin, MD

Am J Dis Child. 1984;138(5):434-438.


Abstract

• Beginning in 1979, OKA and KMcC strains of varicella zoster virus (VZV) vaccine were administered to 369 healthy seronegative children in a sequence of ten comparative clinical trials. Postimmunization clinical reactivity was minimal with the OKA vaccines but was unacceptably high (32%) with the KMcC passage-40 vaccine. Ninety-three percent to 100% immunogenicity was noted by fluorescent antibody assay and in vitro lymphocyte proliferation to VZV antigens. Follow-up studies demonstrated persistence of antibody and in vitro lymphocyte proliferation responses and protection or modification of infection nine to 48 months after immunization. Only five episodes of mild varicella occurred in children in whom seroconversion had occurred. These episodes were noted after at least 281 known varicella exposures. Vaccine virus reactivation as zoster had not occurred in any child.

(AJDC 1984;138:434-438)



Author Affiliations

From the Department of Pediatrics, Temple University School of Medicine, Philadelphia (Dr Arbeter); Department of Pediatrics, Albert Einstein Medical Center, Philadelphia (Dr Arbeter); Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia (Drs Starr and Plotkin); Division of Immunizations, Center for Preventive Services, Centers for Disease Control, Atlanta (Dr Preblud); Department of Pediatrics, Mie University School of Medicine, Tsucity, Mie, Japan (Dr Ihara); and Division of Infectious Diseases, Department of Pediatrics, The Children's Hospital of Philadelphia (Drs Starr and Plotkin and Mss Paciorek, Miller, Zelson, and Proctor).


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nosocomial Spread of Viral Disease
Aitken and Jeffries
Clin. Microbiol. Rev. 2001;14:528-546.
ABSTRACT | FULL TEXT  

Vaccination of Children in Japan
Nishi et al.
Asia Pac J Public Health 1990;4:128-131.
ABSTRACT  

Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention
STRAUS et al.
ANN INTERN MED 1988;108:221-237.
ABSTRACT  

Whither Immunization Against Viral Infections?
HILLEMAN
ANN INTERN MED 1984;101:852-858.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.